SHANX MEDTECH - Key Persons
Ardjan van der Linden, PhD, has been serving as the Chief Scientific Officer at ShanX Medtech BV since 2021. He holds a PhD in Synthetic & Chemical Biology from the Eindhoven University of Technology. Herein, he studied cell-free genetic networks. Ardjan further holds an MSc and a BSc in Biomedical Engineering from Eindhoven University of Technology and has co-authored 10 scientific publications.
Ardjan's combination of diverse scientific and engineering skills obtained from the Eindhoven University of Technology enables him to design innovative assays that address critical healthcare needs, driving innovation and shaping the future of diagnostic medicine.
Job Titles:
- Head of the Clinical Microbiology Department at the University Hospital
Rafael Cantón is Head of the Clinical Microbiology Department at the University Hospital Ramón y Cajal in Madrid (Spain) and Associate Professor of Clinical Microbiology at Complutense University in Madrid. His research activity is developed within the Spanish Network CIBER in Infectious Diseases and Institute Ramón y Cajal for Health (IRYCIS) in which he coordinates the Microbiology, Immunology and Infection Area. This activity is focused on antimicrobial resistance mechanisms, including extended-spectrum beta-lactamases and carbapenemases, antimicrobial susceptibility testing with new rapid technology, respiratory tract infections (mainly in bronchiectasis and cystic fibrosis), and interplay of clonal epidemiology and resistance.
He is currently the clinical data coordinator of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) (former president 2012 - 2016). He has been President of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (2015-2017). Since 2018 he is in the Advisory Board of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR).
Job Titles:
- General Practitioner and Former Innovation Specialist at Star - Shl
Rogier Hopstaken (MD PhD) is a general practitioner and former innovation specialist at Star-Shl diagnostic centers, a cooperation delivering diagnostic services to over 2000 general practitioners in the Netherlands. His special interests are point-of-care testing (POCT), respiratory tract infections and antibiotic stewardship.
Dr Hopstaken is a member of several working groups in the Dutch College of General Practitioners (NHG), co-authoring guidelines on acute cough and rational laboratory testing. He is the principal author of the Dutch, multidisciplinary guideline on POCT in general practice. He is also chairing the Special Interest Group POCT for the World Organization of Family Doctors (WONCA).
Carmen van Vilsteren is Director Strategic Area Health of Eindhoven University of Technology (TU/e), and Chair of the Dutch Life Sciences & Health Top Sector, a high-profile body established by the Netherlands' Ministry of Economic Affairs.
In the past she chaired the EIT Health Belgium / Netherlands Supervisory Board and she has been active in both startups and multinationals (Philips) in MedTech and later on as a cofounder and CEO of microsurgical robots. Carmen has a passion for innovation in Healthcare, and on generating impact on the health of people.
Job Titles:
- Chief Executive Officer
- Founder of Shan
Sophia E. Shanko, PhD, is the founder of ShanX Medtech BV and has been serving as the Chief Executive Officer, bringing a unique blend of technical expertise and entrepreneurial acumen to the role.
Sophia holds a PhD in "Magnetic Micromixing for Point-of-Care Diagnostics" from Eindhoven University of Technology (Mechanical Engineering). During her studies, she developed a microfluidic device to study biosensor-antibody interactions and improved assay kinetics through micromixing. She also holds an EU-financed MSc in Semiconductors (Electrical Engineering) from Heriot-Watt University (HW, UK), Universitetet i Sørøst-Norge (USN, NO), Budapest University of Technology and Economics (BME, HU), and Eidgenössische Technische Hochschule Zürich (ETH, CH), where she developed a microfluidic device for Antibiotic Susceptibility Testing. Additionally, she has a BSc in Control Systems (Electrical Engineering) from the University of Applied Sciences of Piraeus (GR). During her undergraduate studies, she invented and developed a Wireless Medical Emergency Gear for post-operative patient monitoring as early as 2012.
Sophia founded SXM with the vision to create a new standard of care supported by evidence-based antibiotic decision-making, a need derived from her family's experience with a mismanaged bacterial infection.
Ardjan van der Linden, PhD, has been serving as the Chief Scientific Officer at ShanX Medtech BV since 2021. He holds a PhD in Synthetic & Chemical Biology from the Eindhoven University of Technology. Herein, he studied cell-free genetic networks. Ardjan further holds an MSc and a BSc in Biomedical Engineering from Eindhoven University of Technology and has co-authored 10 scientific publications.
Ardjan's combination of diverse scientific and engineering skills obtained from the Eindhoven University of Technology enables him to design innovative assays that address critical healthcare needs, driving innovation and shaping the future of diagnostic medicine.
Marcel van Kasteel has over 30 years of experience in the Diagnostics Market. He held senior management positions, advisory and business development roles in the Diagnostic Market. He is founder and owner of Van Kasteel Business Accelerator B.V. to support start-up and large IVD companies in growing businesses in Europe and USA. He was Vice- President Europe Middle East & Africa at Beckman Coulter , based in Switzerland and CEO of Philips Handheld Diagnostics in Eindhoven and responsible for the development and launch of the POCT MiniCare system in Europe.